Characteristics | Entire sample, n (%) | Dead, n (%) | ||||
---|---|---|---|---|---|---|
HIV+ (N = 13729) | HIV- (N = 510313) | p-value | HIV+ (N = 3401) | HIV- (N = 47647) | p-value | |
Age at study entry, median (Q1, Q3) years | 38 (32, 46) | 36 (24, 50) | <0.001 | 41 (34, 49) | 71 (59, 78) | <0.001 |
Age at death, median (Q1, Q3) years | Â | Â | Â | 46 (39, 55) | 80 (69, 87) | <0.001 |
Sex | ||||||
 Male | 11017 (80.25) | 256440 (50.25) | <0.001 | 2716 (79.86) | 24394 (51.20) | <0.001 |
 Female | 2712 (19.75) | 253873 (49.75) | 685 (20.14) | 23253 (48.80) | ||
Follow-up time, median (Q1, Q3) years | 7.22 (2.96, 12.97) | 12.70 (4.76,16.75) | <0.001 | 3.91 (1.16, 7.60) | 8.42 (4.25, 12.58) | <0.001 |
Antiretroviral therapy ever? | ||||||
 Yes | 10165 (74.04) |  |  | 2377 (69.89) |  |  |
 No | 3564 (25.96) | -- |  | 1024 (30.11) | -- |  |